COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,608,225 | +9.4% | 964,766 | +24.9% | 0.00% | -100.0% |
| Q2 2023 | $3,298,593 | +27.3% | 772,504 | +103.9% | 0.00% | 0.0% |
| Q1 2023 | $2,591,813 | +22.2% | 378,920 | +41.5% | 0.00% | – |
| Q4 2022 | $2,121,356 | +64.7% | 267,848 | +100.0% | 0.00% | – |
| Q3 2022 | $1,288,000 | +108.8% | 133,942 | +57.1% | 0.00% | – |
| Q2 2022 | $617,000 | -35.9% | 85,254 | +14.4% | 0.00% | – |
| Q1 2022 | $962,000 | -69.5% | 74,524 | -62.3% | 0.00% | – |
| Q4 2021 | $3,152,000 | +66.8% | 197,512 | +67.9% | 0.00% | – |
| Q3 2021 | $1,890,000 | +9.2% | 117,611 | -6.0% | 0.00% | – |
| Q2 2021 | $1,731,000 | +18.6% | 125,124 | +25.3% | 0.00% | – |
| Q1 2021 | $1,459,000 | -65.7% | 99,898 | -59.2% | 0.00% | – |
| Q4 2020 | $4,252,000 | +63.4% | 244,694 | +72.5% | 0.00% | – |
| Q3 2020 | $2,602,000 | +20.5% | 141,858 | +17.3% | 0.00% | – |
| Q2 2020 | $2,160,000 | -53.5% | 120,958 | -57.7% | 0.00% | -100.0% |
| Q1 2020 | $4,643,000 | +11.8% | 286,244 | +24.1% | 0.00% | – |
| Q4 2019 | $4,152,000 | -19.2% | 230,632 | -9.1% | 0.00% | -100.0% |
| Q3 2019 | $5,139,000 | -49.6% | 253,687 | -45.0% | 0.00% | +100.0% |
| Q2 2019 | $10,190,000 | +1988.1% | 461,118 | +1188.0% | 0.00% | – |
| Q1 2019 | $488,000 | -44.5% | 35,800 | -63.1% | 0.00% | – |
| Q4 2018 | $879,000 | -76.3% | 97,090 | -56.8% | 0.00% | -100.0% |
| Q3 2018 | $3,713,000 | +7.6% | 225,000 | -8.7% | 0.00% | -50.0% |
| Q2 2018 | $3,451,000 | +552.4% | 246,500 | +414.3% | 0.00% | – |
| Q1 2018 | $529,000 | +178.4% | 47,931 | +121.9% | 0.00% | – |
| Q4 2017 | $190,000 | -86.3% | 21,600 | -79.2% | 0.00% | – |
| Q3 2017 | $1,386,000 | -34.3% | 103,800 | -29.4% | 0.00% | – |
| Q2 2017 | $2,111,000 | +56.5% | 147,047 | +130.5% | 0.00% | – |
| Q1 2017 | $1,349,000 | +60.4% | 63,800 | +113.5% | 0.00% | – |
| Q4 2016 | $841,000 | +9.8% | 29,884 | +4.5% | 0.00% | – |
| Q3 2016 | $766,000 | +62.6% | 28,600 | +21.7% | 0.00% | – |
| Q3 2015 | $471,000 | +26.6% | 23,500 | +3.2% | 0.00% | – |
| Q4 2014 | $372,000 | – | 22,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |